TRT

Overview

What is TRT?

Testosterone Replacement Therapy (TRT) is FDA-approved for treating male hypogonadism (low testosterone) caused by testicular failure or hypothalamic-pituitary dysfunction. Testosterone cypionate and enanthate are the most commonly prescribed injectable esters, providing sustained testosterone levels with weekly or bi-weekly dosing. The TRAVERSE trial (5,200+ participants) confirmed cardiovascular safety in high-risk men when used as indicated.

Key Benefits

Most effective TRT delivery method with predictable testosterone levels. Intramuscular or subcutaneous administration provides sustained release over 7-8 days. Significantly improves energy, libido, mood, muscle mass, and bone density in hypogonadal men.

Mechanism of Action

Testosterone esters (cypionate/enanthate) are dissolved in oil and injected, where they slowly release testosterone as the ester bond is cleaved. Cypionate has ~8-day half-life, enanthate ~7 days. Testosterone then binds to androgen receptors, modulating gene expression for anabolic and androgenic effects.

Pharmacokinetics

Peak: 2 days Half-life: 5 days - 8 days Cleared: 25 days - 40 days

Research Indications

Hormone Restoration Most Effective

Testosterone Normalization

Restores serum testosterone to physiological range (400-700 ng/dL) in hypogonadal men with documented deficiency.

Symptom Resolution

Improves low testosterone symptoms: fatigue, low libido, erectile dysfunction, depressed mood, and cognitive fog.

Fertility Considerations

Exogenous testosterone suppresses sperm production. hCG co-administration may preserve fertility during TRT.

Body Recomposition Effective

Lean Mass Increase

Meta-analyses show 3-6kg lean mass gains with TRT, with intramuscular showing greater effects than transdermal.

Fat Mass Reduction

Studies demonstrate 2-4kg fat loss, particularly visceral fat, with testosterone optimization.

Muscle Strength

10-13% improvement in muscle strength measures reported in clinical trials of hypogonadal men.

Metabolic Health Moderate

Insulin Sensitivity

TRT may improve insulin sensitivity and glucose metabolism, with TRAVERSE showing reduced diabetes progression.

Cardiovascular Safety

TRAVERSE trial confirmed TRT noninferior to placebo for major adverse cardiac events in high-risk men.

Bone Density

Testosterone maintains bone mineral density. Note: TRAVERSE substudy unexpectedly showed increased fracture risk.

Research Protocols

Disclaimer

TRT is typically a lifelong commitment for diagnosed hypogonadism. Exogenous testosterone suppresses natural production via HPG axis feedback. Discontinuation requires medical supervision and may involve PCT protocols (clomiphene, hCG) to restore endogenous production, though recovery is not guaranteed. This is educational research information, not medical advice, and not a substitute for guidance from a qualified healthcare provider.

Goal	Dose	Frequency	Route
Standard TRT	100-200mg	Weekly or split 2x/week	IM or SubQ
Conservative Start	75-100mg	Weekly	IM or SubQ
Stable Levels (Split)	50-100mg	Every 3.5 days	SubQ preferred
With hCG (Fertility)	100-150mg + 250-500 IU hCG	T weekly, hCG 2-3x/week	IM/SubQ + SubQ

Timing

Inject on consistent days each week. For twice-weekly dosing, space injections 3.5 days apart (e.g., Monday AM/Thursday PM). Morning injections loosely mimic natural testosterone rhythm. Draw blood for labs at trough (before next injection) for accurate level assessment.

Peptide Interactions

hCG Synergistic

hCG maintains testicular function and fertility during TRT by mimicking LH. Commonly dosed at 250-500 IU 2-3x weekly.

Anastrozole Unknown

Aromatase inhibitor that prevents testosterone-to-estrogen conversion. Used at 0.5-1mg weekly if estradiol elevates.

Growth Hormone Peptides Synergistic

GH secretagogues (Ipamorelin, CJC-1295) may enhance body composition effects when combined with TRT.

Insulin Monitor Combination

TRT may improve insulin sensitivity and reduce blood glucose; diabetics may need medication dose adjustments.

Blood Thinners Monitor Combination

TRT can increase hematocrit and hemoglobin. Monitor closely if on anticoagulants due to altered blood viscosity.

Clomiphene Unknown

SERM used as alternative to TRT or for PCT. Not typically combined during active TRT as they work through opposing mechanisms.

How to Reconstitute

Important

Always use bacteriostatic water (BAC). Sterile technique is essential.

1
No reconstitution needed - testosterone comes as ready-to-use oil solution
2
Warm vial briefly in hands if oil is thick (do not heat excessively)
3
Clean vial stopper with alcohol swab
4
Draw air equal to dose volume, inject into vial to ease drawing
5
Invert vial and draw prescribed dose slowly (oil is viscous)
6
Switch to injection needle if using separate draw needle
7
Clean injection site, insert needle, aspirate briefly, inject slowly
8
Dispose of needles in sharps container

Quality Indicators

✓

Pharmaceutical Grade Product

Use only FDA-approved testosterone from licensed pharmacies. Brand names: Depo-Testosterone (cypionate), Delatestryl (enanthate).
✓

Clear Oil Solution

Testosterone should be clear, yellowish oil. No particles, cloudiness, or crystallization visible.
✓

Proper Storage Verification

Stored at controlled room temperature. If crystallized from cold exposure, warm gently until dissolved.
!

Compounded Testosterone

Compounded products may vary in quality. Use only from licensed compounding pharmacies with COA available.
X

Underground Lab (UGL) Products

UGL testosterone has inconsistent dosing (25-400% of labeled amount), contamination risks, and no quality control.
X

Crystallized or Cloudy Solution

Crystallization from cold exposure requires gentle warming. Persistent cloudiness or particles indicates contamination.

What to Expect

Week 1-3: Initial adjustment, possible mood fluctuations as levels stabilize
Week 3-6: Improved energy, mood, mental clarity, and libido typically begin
Month 2-3: Enhanced recovery from exercise, improved sleep quality
Month 3-6: Body composition changes become noticeable (muscle gain, fat loss)
Month 6-12: Bone density improvements, sustained metabolic benefits
Ongoing: Continued benefits require continued treatment; cessation reverses effects

Side Effects & Safety

Requires diagnosis of hypogonadism with documented low testosterone (<300 ng/dL) plus symptoms
Regular monitoring required: testosterone, hematocrit, PSA, estradiol every 3-6 months initially
Hematocrit >54% requires intervention (dose reduction, therapeutic phlebotomy)
Not for use by women (especially pregnant), children, or men with prostate/breast cancer
May cause testicular atrophy and infertility - discuss hCG if fertility desired
FDA black box warning: possible increased risk of heart attack and stroke

Hematocrit consistently above 54% (polycythemia risk)
Significant PSA elevation (>1.4 ng/mL increase or >4 ng/mL total)
Signs of sleep apnea worsening (snoring, daytime fatigue)
Severe acne or significant hair loss if distressing
Mood instability, aggression, or significant personality changes
Lower extremity edema or signs of heart failure
Any symptoms of venous thromboembolism (leg pain, swelling, shortness of breath)

References

TRAVERSE Cardiovascular Safety Trial (2023)

5,246 men | 45-80 years | Mean 33 months | FDA-mandated study

Landmark randomized trial in hypogonadal men with cardiovascular disease or high CV risk. Found TRT noninferior to placebo for major adverse cardiac events, establishing cardiovascular safety when used as indicated.

View Study →

Testosterone Trials (TTrials) - Body Composition (2017)

788 men ≥65 years | 1 year | Multiple endpoints

Comprehensive NIH-funded study showing testosterone gel increased lean mass, improved sexual function, mood, and walking distance in older hypogonadal men.

View Study →

Meta-Analysis: Muscular Responses to TRT (2018)

31 RCTs analyzed | Various formulations | Fat-free mass outcomes

Intramuscular TRT associated with 5.7% increase in fat-free mass and 10-13% improvement in muscle strength. Transdermal showed 1.7% fat-free mass increase.

View Study →

Long-Term Safety Registry Study (2016)

1,000+ men | Up to 12 years | Real-world outcomes

Long-term registry data showing sustained improvements in metabolic parameters, body composition, and quality of life with continued TRT over many years.

View Study →